...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces US$30 Million Loan Commitment Letter .

I just re-posted the news as a press release. Remember all you early birds who post company news releases .....when you post to Agoracom, please toggle the "Press Release" button before posting. The default is standard "Message". Toggling "Press Release" allows the post/news release to appear in the "Recent Updates" on the Hub Homepage. Thanks!

Great news today. Was this needed in advance of the TSX de-listing review, or just coincidental that the news came the day before the April 12 date of the de-listing review?

Now that the company has more $, will the Renal and Fabry trials begin this quarter? According to the respective ClinicalTrials.gov entries: 

Renal (last updated 12/15/17): Anticipated study start March 15, 2018

Fabry (last updated 10/24/17): Anticipated study start April 30, 2018

 

Share
New Message
Please login to post a reply